(PhysOrg.com) -- In what can only be described as insightful, two doctors from The Netherlands, working with Italian imaging companies, have devised a means to use ultrasound to measure blood pressure. The technology, more ...
(Medical Xpress) -- Researchers are a step closer towards creating a new class of medicines and vaccines to combat drug-resistant and deadly strains of fungal infections, following a new study published today in Proceedings ...
Sep 5, 2011
0
0
A new study by a Yale researcher may support the use of a device for patients suffering from irregular heart rhythms.
Jun 16, 2016
0
99
National Institutes of Health (NIH) scientists have identified a promising lead for developing a new type of drug to treat infection caused by Staphylococcus aureus, a bacterium that frequently resists traditional antibiotics.
Feb 10, 2013
1
0
Researchers at the University of Toronto have developed a therapy for a potentially deadly type of infection common in catheters, artificial joints and other "in-dwelling" medical devices. Their findings appear in the Open ...
Sep 8, 2011
0
0
Interventional cardiologists at the UW Medicine Heart Institute in Seattle recently performed a first-in-human procedure, successfully employing a catheter-delivered device to retrieve a benign tumor from inside a patient's ...
Aug 18, 2022
0
11
A team of researchers led by Nanyang Technological University, Singapore (NTU Singapore) has developed a device that offers a quicker and less invasive way to seal tears and holes in blood vessels, using an electrically-activated ...
May 3, 2021
1
106
Most women diagnosed with ovarian cancer undergo surgery to remove as many of the tumors as possible. However, it is usually impossible to eliminate all of the cancer cells because they have spread throughout the abdomen. ...
May 23, 2017
0
37
(AP) -- "Maxed out on the medications," is how Bill Ezzell describes his struggle with blood pressure. It's dangerously high even though the North Carolina man swallows six different drugs a day.
May 28, 2012
0
0
What began in the Dentistry lab of Professor Paul Santerre more than a decade ago is now Interface Biologics Inc. (IBI) - a privately-held company poised to transform the market for medical devices in the United States.
Sep 19, 2012
0
0
